How Do Clinical Trials Work? A Step-by-Step Guide

Introduction: How Clinical Trials Work From a Volunteer’s Perspective

Clinical trials are research studies involving human volunteers designed to answer specific questions about whether new drugs, vaccines, medical devices, or procedures are safe and effective enough to reach the people who need them. These medical studies follow a carefully structured, step-by-step process-called phases-and operate under strict rules set by regulators like the U.S. Food and Drug Administration (FDA) and independent ethics committees.

Clinical trials have four distinct phases, each building on the findings of the one before it. If you have ever wondered what happens during a clinical trial, this article walks you through the entire experience from a volunteer’s perspective: screening, treatment, follow-up, and everything in between.

One thing worth knowing from the start: participants can withdraw from a trial at any time, for any reason, without penalty. You are closely monitored by a dedicated research team, your rights are protected throughout, and your standard medical care does not disappear if you decide the trial is not for you.

Before Day One: From Pre-Clinical Research to Trial Approval

Long before a clinical trial volunteer walks through the door, years of behind-the-scenes work have already taken place. A potential treatment starts in the lab, where researchers study how it interacts with cells, tissues, and eventually animals. These preclinical studies examine toxicity, how the body processes the substance, and early signs of whether it might treat diseases effectively. The entire clinical trial process can take 10 to 15 years from discovery to approval-and much of that time is spent before a single human participant is enrolled.

Once preclinical data looks promising, the sponsor submits an Investigational New Drug (IND) application to the FDA, requesting permission to begin testing in people. Clinical trials require approval from an institutional review board for participant protection. This independent board reviews the clinical trial protocol-a detailed research plan developed for each study outlining objectives, methods, visit schedules, and safety monitoring procedures. Clinical trials may test new drugs not yet approved for use, so these safeguards exist to ensure risks are minimized before anyone volunteers.

Participants will not see this preclinical and regulatory work, but it directly shapes what happens during the trial: which tests are ordered, how often visits occur, and what safety rules are in place.

Joining a Clinical Trial: Referral, Search, and First Contact

People learn about clinical trials in several ways. Your physician might suggest one based on your specific disease or health conditions, you may search a public registry like ClinicalTrials.gov, or you could hear about research studies through a patient advocacy group or local medical centers.

When reviewing a trial, you will typically see basic details including:

• The condition studied (for example, type 2 diabetes or a particular cancer)
• Location of the research site-hospitals, doctors offices, or dedicated research facilities
• Study duration (such as 6 or 12 months)
• Key eligibility criteria, sometimes called eligibility criteria, that determine who can join a clinical trial

Research team members-often a study coordinator or research nurse-handle the first phone call or online form. They ask initial questions about your medical history and current medications to gauge whether the trial might be a fit. Eligibility criteria vary by study and research question, so this early conversation is exploratory. No commitments are made, and the only goal is to decide whether scheduling a screening visit makes sense.

Informed Consent: Understanding the Study Before You Say “Yes”

Informed consent is a process before joining a study-not simply a piece of paper you sign. It is an ongoing conversation between you and the research team designed so you fully understand what participation means before, during, and after the clinical trial. Informed consent is required before joining a clinical trial, and it is one of the most important protections you have as a clinical trial volunteer.

The informed consent document covers several key areas:

• Purpose of the clinical research and what researchers hope to learn
• Study design, including randomization, blinding, and whether a comparator or placebo is used
• Number and frequency of visits and specific procedures at each one
• Possible benefits and known or unknown risks-informed consent documents list risks and potential benefits so you can weigh them carefully
• Alternative treatment options, including not participating
• Privacy protections and how your data will be handled
• Financial details such as costs covered, travel reimbursement, or stipends

You should expect to meet with research team members-such as the principal investigator or a study nurse-who will walk through each section, encourage questions, and confirm your understanding in plain language. The informed consent form, sometimes called informed consent, helps participants understand study details thoroughly.

Signing the consent form means you agree to participate, but signing informed consent does not obligate participation permanently. You retain the right to withdraw at any time without losing access to standard medical treatment. For children, a parent or legal guardian provides consent, and older children may give “assent” in age-appropriate language.

Screening: Eligibility Tests and Baseline Assessments

Screening is the first active stage of participation. During this phase, the study team checks whether you meet the trial’s eligibility criteria and collects baseline data-a snapshot of your health before any study treatment begins. Participants undergo health screenings to assess eligibility, and screening includes medical history and physical examinations.

Typical screening activities include:

• Detailed review of your medical history, surgeries, allergies, and current medicines
• Physical exam and measurement of vital signs (blood pressure, heart rate, temperature)
• Blood and urine tests, including chemistry panels and hematology
• ECG or EKG to assess heart function
• Pregnancy tests when applicable
• Disease-specific diagnostics such as tumor imaging, lung function tests, or biomarker analysis

Inclusion criteria might specify an age range, a particular disease stage, or prior treatments you have received. Exclusion criteria-such as certain other health conditions, abnormal lab values, or conflicting medications-exist because eligibility criteria help ensure participant safety during trials and protect the scientific integrity of the data.

Sometimes screening requires more than one visit or additional tests. Some people do not qualify even after completing screening. This is not a personal rejection; it is about making sure the trial is safe and its results are meaningful. All information collected at this stage is kept confidential under privacy laws like HIPAA in the United States or GDPR in Europe.

Clinical Trial Phases: What Happens in Phase I, II, III, and IV

Most interventional clinical trials move through four phases of clinical trials, sometimes called phases, each answering different questions and involving progressively more participants. Understanding the clinical trial phases helps you know where a study falls in the development timeline.

Phase I – Phase 1 tests safety and dosage in a small group. Phase I trials typically involve 20 to 100 participants, and researchers learn how the investigational medicine moves through the body, what side effects occur, and what dose is tolerable. Participants in Phase I trials are usually healthy volunteers or patients with the target condition, depending on whether the treatment targets a serious or life-threatening disease. Approximately 70% of drugs progress from Phase I to Phase II.

Phase II – Phase 2 evaluates effectiveness and side effects in more participants. Phase ii trials typically test several hundred patients with the target condition. Phase II trials evaluate a treatment’s effectiveness and side effects while refining optimal dosing. These studies often include a treatment group and a control group to begin comparing outcomes.

Phase III – Phase 3 compares the new treatment to standard treatments. Phase iii trials can involve between 300 to 3,000 participants or more across multiple countries. Phase III trials involve large participant groups to confirm effectiveness and generate the data regulators need for approval decisions. Participants may receive new treatments not yet approved, existing treatments, or a placebo, depending on the study design.

Phase IV – Phase 4 occurs after FDA approval to monitor long-term effects. Phase IV trials gather information on treatment’s performance in the general population, detect rare or delayed side effects, and sometimes explore new uses or dosing schedules. These post-marketing studies continue to monitor rare side effects and long-term effectiveness once the medical treatment is widely available.

The Research Team: Who Looks After You During the Trial?

Many clinical trials work thanks to a multidisciplinary research team, and you will interact with multiple research team members across your visits.

• Principal investigator (PI): Usually a physician or experienced scientist who leads the study at the site, makes medical decisions about your care, and ensures the clinical trial protocol is followed precisely.
• Study coordinators and research nurses: Your main day-to-day contacts. They schedule visits, explain procedures, guide the informed consent process, collect data, and answer questions between appointments.
• Pharmacists: Manage and dispense study medicine or investigational medicine, ensuring correct doses reach the right participants.
• Lab technicians: Process blood, urine, and tissue samples collected during visits.
• Data managers: Record and verify the data that flows from each visit into the study database.
• Safety monitors and DSMBs: Independent Data Safety Monitoring Boards review accumulating safety and efficacy data in larger phase II and phase III trials and can recommend protocol changes or early trial termination.

Think of the research team as partners in your care. You can-and should-contact them anytime you experience new symptoms, have questions about the research plan, or feel concerned about possible risks.

During the Trial: Study Visits, Procedures, and Daily Life

What happens during a clinical trial depends on the protocol, but nearly all trials involve people attending regular study visits over weeks, months, or years. All clinical research involves some level of risk to participants, so visits are structured to catch problems early and track how the treatment works.

A typical visit follows a predictable flow:

1. Check-in with the study coordinator
2. Review of symptoms and side effects since your last visit
3. Vital signs measurement (blood pressure, pulse, temperature)
4. Study treatment administration-whether that is taking study medicine, receiving an infusion, or using a medical device
5. Blood draws, imaging, or other procedures specified by the protocol
6. Time with the investigator to discuss how you are feeling and address concerns

In randomized trials, participants are randomly assigned to different treatment groups-you might receive the new treatment, an existing approved therapy, or a placebo. A computer handles this assignment to prevent bias, and in double-blinded studies, neither you nor certain staff members know which group you are in. This blinding helps researchers learn whether the treatment genuinely works without expectations influencing results.

Between visits, daily life during a trial involves responsibilities:

• Keeping a symptom diary or using wearable devices and mobile apps
• Following dosing instructions exactly
• Reporting hospitalizations, new medications, or changes to your healthcare providers
• Adhering to protocol rules about pregnancy prevention, alcohol, diet, or other treatments

Clinical trial data must comply with Good Clinical Practice guidelines, so accuracy in your reporting matters. It is also important to understand that participants may not benefit personally from clinical trials-the primary goal is advancing knowledge, though closer monitoring by specialists is a meaningful advantage for many people.

Monitoring Safety and Managing Risks Throughout the Trial

Participant safety-volunteer safety-is the highest priority across every stage of clinical research. Adverse events during clinical trials are closely monitored and reported. At each visit, the study team asks about new or worsening symptoms, and serious adverse events (life-threatening reactions, hospitalizations, or disabilities) are reported quickly to the sponsor, the institutional review board, and regulators.

The clinical trial protocol includes predefined stopping rules. If certain lab values shift or specific side effects reach a threshold, the investigator may lower your dose, pause your treatment, or permanently stop the investigational product. Ethics review committees ensure risks are acceptable and minimized throughout the study, and their oversight does not end once the trial begins.

For larger phase II and phase III trials, independent Data Safety Monitoring Boards periodically review aggregated, unblinded data from all sites. They have the authority to recommend changes, temporary halts, or early termination if strong benefit or concerning harm emerges. Research shows that approximately 25–30% of trials are terminated prematurely, with poor recruitment being the most common reason-but safety signals can also trigger early closure.

If side effects become unacceptable, you can withdraw at any time. Participants can withdraw from a study at any time, and your clinical care will transition back to standard treatment guided by your usual healthcare providers. No one will penalize you for prioritizing your well-being.

End of Treatment, Follow-Up, and What Happens After a Clinical Trial

The “end of treatment” visit is not always the end of your involvement. Many clinical trials include follow-up visits or phone calls for months-sometimes years-afterward.

At the final treatment visit, you typically undergo:

• A comprehensive physical exam and lab tests
• Assessment of participants health, including side effects and overall response
• Discussion about whether to continue with standard treatment, transition to an open-label extension, or explore other treatment options outside the trial

Post-treatment follow-up involves scheduled check-ins to monitor long-term safety, durability of response, and any late-onset side effects. This information is vital for understanding how a next phase of development should proceed and for the national institutes and regulatory bodies evaluating the treatment.

Once the last participant completes their last visit, after completion, the trial database is locked to ensure data integrity. Researchers then analyze results, comparing outcomes between different groups statistically. Favorable clinical trial results lead to applications for marketing approval to regulatory authorities like the FDA or the European Medicines Agency (EMA). Publishing clinical trial results helps inform future research and healthcare practices, so findings are shared through peer-reviewed journals and public registries.

Participants may receive a summary of results once available-often months or a few years later. Even if the treatment is not approved, your contribution advances medical knowledge and shapes future clinical trials. The National Cancer Institute and other organizations emphasize that every trial, regardless of outcome, moves science forward.

Deciding Whether to Join a Clinical Trial: Benefits, Burdens, and Key Questions

Deciding to join a clinical trial is a deeply personal choice, and there is no universal right answer. The decision should weigh potential benefits against potential risks and practical burdens like travel, time away from work, and family schedules, along with other factors unique to your situation.

Potential benefits include:

• Early access to new treatments before they are widely available
• Closer monitoring by specialists who focus on your specific disease
• Contributing to better care for future patients
• Travel reimbursement or small stipends in some research studies

Potential burdens and risks include:

• Unknown side effects-all clinical research carries some level of risk
• Extra clinic visits, procedures, and time commitments
• The chance of being assigned to a placebo or standard treatment rather than the new drug
• Possible impacts on work, family, and daily routines

Questions worth asking the research team before enrolling:

• What phase is this trial in, and how does that affect what I experience?
• What will happen at each visit, and how long will the trial last?
• How are emergencies handled, and who do I call after hours?
• What costs are covered, and what might I be responsible for?
• How is my data and privacy protected?
• What are the possible risks and potential benefits specific to this study?

Talking with both the study team and your regular doctor can help you decide whether a particular clinical trial is the right choice at this moment. No one should pressure you, and taking time to ask questions-and truly understand the answers-is exactly how the process is designed to work.

See If You Qualify For One Of Our Studies

Ready to Learn More About Clinical Trials?

Understanding how clinical trials work is the first step toward making an informed decision about participating in medical research. If you’re interested in contributing to future medical advancements or exploring research opportunities, ARI can help you find studies that may be a good fit for your health needs.

Browse our current clinical trials and see if you may qualify today.